Marcus Ulrich, Schink Susanne Barbara, Sherriff Nigel, Jones Anna-Marie, Gios Lorenzo, Folch Cinta, Berglund Torsten, Nöstlinger Christiana, Niedźwiedzka-Stadnik Marta, Dias Sonia F, Gama Ana F, Naseva Emilia, Alexiev Ivailo, Staneková Danica, Toskin Igor, Pitigoi Daniela, Rafila Alexandru, Klavs Irena, Mirandola Massimo
Department of Infectious Diseases Epidemiology, Robert Koch-Institute, Berlin, Germany.
University of Brighton, Health Sciences, Brighton, UK.
BMC Infect Dis. 2017 Nov 25;17(1):730. doi: 10.1186/s12879-017-2814-x.
BACKGROUND: Knowledge of HIV status can be important in reducing the risk of HIV exposure. In a European sample of men-who-have-sex-with-men (MSM), we aimed to identify factors associated with HIV serostatus disclosure to the most recent anal intercourse (AI) partner. We also aimed to describe the impact of HIV serostatus disclosure on HIV exposure risks. METHODS: During 2013 and 2014, 4901 participants were recruited for the bio-behavioural Sialon-II study in 13 European cities. Behavioural data were collected with a self-administered paper questionnaire. Biological specimens were tested for HIV antibodies. Factors associated with HIV serostatus disclosure with the most recent AI partner were examined using bivariate and multilevel multivariate logistic regression analysis. We also describe the role of serostatus disclosure for HIV exposure of the most recent AI partner. RESULTS: Thirty-five percent (n = 1450) of the study participants reported mutual serostatus disclosure with their most recent AI partner or disclosed having HIV to their partner. Most of these disclosures occurred between steady partners (74%, n = 1077). In addition to the type of partner and HIV diagnosis status, other factors positively associated with HIV serostatus disclosure in the multilevel multivariate logistic regression model were recent testing, no condom use, and outness regarding sexual orientation. Disclosure rates were lowest in three south-eastern European cities. Following condom use (51%, n = 2099), HIV serostatus disclosure (20%, n = 807) was the second most common prevention approach with the most recent AI partner, usually resulting in serosorting. A potential HIV exposure risk for the partner was reported by 26% (111/432) of HIV antibody positive study participants. In 18% (20/111) of exposure episodes, an incorrect HIV serostatus was unknowingly communicated. Partner exposures were equally distributed between steady and non-steady partners. CONCLUSIONS: The probability of HIV exposure through condomless AI is substantially lower after serostatus disclosure compared to non-disclosure. Incorrect knowledge of one's HIV status contributes to a large proportion of HIV exposures amongst European MSM. Maintaining or improving condom use for anal intercourse with non-steady partners, frequent testing to update HIV serostatus awareness, and increased serostatus disclosure particularly between steady partners are confirmed as key aspects for reducing HIV exposures amongst European MSM.
背景:了解艾滋病毒感染状况对于降低艾滋病毒暴露风险可能很重要。在一个欧洲男男性行为者(MSM)样本中,我们旨在确定与向最近的肛交(AI)伴侣披露艾滋病毒血清学状态相关的因素。我们还旨在描述艾滋病毒血清学状态披露对艾滋病毒暴露风险的影响。 方法:在2013年至2014年期间,在欧洲13个城市招募了4901名参与者参加生物行为Sialon-II研究。通过自行填写的纸质问卷收集行为数据。对生物标本进行艾滋病毒抗体检测。使用双变量和多水平多变量逻辑回归分析检查与向最近的AI伴侣披露艾滋病毒血清学状态相关的因素。我们还描述了血清学状态披露对最近的AI伴侣艾滋病毒暴露的作用。 结果:35%(n = 1450)的研究参与者报告与他们最近的AI伴侣相互披露了血清学状态,或向伴侣披露自己感染了艾滋病毒。这些披露大多发生在固定伴侣之间(74%,n = 1077)。在多水平多变量逻辑回归模型中,除了伴侣类型和艾滋病毒诊断状态外,与艾滋病毒血清学状态披露呈正相关的其他因素包括近期检测、未使用避孕套以及性取向的公开程度。东南欧三个城市的披露率最低。在使用避孕套(51%,n = 2099)之后,向最近的AI伴侣披露艾滋病毒血清学状态(20%,n = 807)是第二常见的预防方法,通常会导致血清分类。26%(111/432)的艾滋病毒抗体阳性研究参与者报告其伴侣存在潜在的艾滋病毒暴露风险。在18%(20/111)的暴露事件中,无意中传达了错误的艾滋病毒血清学状态。伴侣暴露在固定和非固定伴侣之间分布均匀。 结论:与未披露血清学状态相比,披露血清学状态后通过无保护肛交感染艾滋病毒的可能性要低得多。对自己艾滋病毒感染状况的错误了解在欧洲男男性行为者中导致了很大一部分艾滋病毒暴露。维持或改善与非固定伴侣肛交时使用避孕套、频繁检测以更新艾滋病毒血清学状态意识以及增加血清学状态披露,特别是在固定伴侣之间,被确认为降低欧洲男男性行为者中艾滋病毒暴露的关键方面。
JMIR Public Health Surveill. 2025-1-13
Viruses. 2020-4-14
BMC Public Health. 2016-3-2
J Acquir Immune Defic Syndr. 2016-6-1
AIDS Patient Care STDS. 2015-10
AIDS Patient Care STDS. 2015-11
AIDS Patient Care STDS. 2014-12